Thymus-based tolerogenic approaches for type i diabetes

Details Thymus-based tolerogenic approaches for type i diabetes Thymus-based tolerogenic approaches for type i diabetes

A - Human Necessities

61

K

A61K 38/30 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2496692

The present invention provides compositions and methods for the treatment and prevention of type I diabetes, comprising IGF-2 peptide.

L'invention concerne des compositions et des méthodes permettant de traiter et de prévenir le diabète de type I.

Affiliated with

Also associated with

Rating

Thymus-based tolerogenic approaches for type i diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thymus-based tolerogenic approaches for type i diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymus-based tolerogenic approaches for type i diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1874166